Search
-
Searchresult: Our team
Physicians Dr. med. Maria Syka Specialist Physician Nurses Simone Kremeier Nurse Britta Mulitze Nurse Volker Müller Nurse Liquid Biopsies…
-
Searchresult: Registration_form_english_2025.doc
Service inquiries at the Core Facility small animal imaging at DKFZ Dr. Manfred Jugold Head of Core Facility small animal imaging/W240 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen…
Document -
Searchresult: What is cancer?
Cancer - a disease of the genes Several steps are necessary to turn cells into cancer cells: tumor suppressor genes, i.e. genes that normally slow down cancer development, are silenced.…
-
Searchresult: Why we cannot do without animal testing in cancer research
According to the WHO, we will see a 20% increase in annual cancer cases in Germany and Europe within 20 years. The task of cancer research is to develop effective prevention and early detection for…
-
Searchresult: SCIENCE@DKFZ
SCIENCE@DKFZ – The DKFZ Internal Seminar SCIENCE@DKFZ aims at increasing the dissemination of scientific results generated at the DKFZ and NCT in Heidelberg. Each edition will feature a…
-
Searchresult: 60 years DKFZ
The German Cancer Research Center was founded a full 60 years ago. On January 28, 1964, the state government of Baden-Württemberg established the public-law "German Cancer Research Center…
-
Searchresult: Distinguished Lecturer Seminar Series
Speaker Suggestion Form DDLSS Past Speakers Upcoming Speakers Prof. Raffaella Di Micco - IRCCS Ospedale San Raffaele Date: 29.06.2026 Time: 11:00 Location: Main…
-
Searchresult: 4-IN-THE-LUNG-RUN
4ITLR International Consortium https://4inthelungrun.com/en-gb/ In this lung cancer screening study, the effectiveness of different screening intervals using low-dose MSCT will be…
-
Searchresult: Our team
The members of our team have complementary backgrounds in (analytical) chemistry, molecular biology, biochemistry, and clinical research. What brings us together is a fascination for mass…
-
Searchresult: Klinische_Studien_01_2025.docx
Klinische Studien - mit möglichem Studieneinschluss R3767-ONC-2011 A Phase 3 Trial of Fianlimab (REGN3767,ANTI-LAG-3) + Cemiplimab versus pemrolizumab in Patients with previously untreated…
Document